Krause, Stefan W and Neumann, Christine and Soruri, Afasaneh and Mayer, Stephanie and Peters, J. Hinrich and Andreesen, Reinhard (2002) The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells. Journal of immunotherapy (Hagerstown, Md. : 1997) 25 (5), pp. 421-8.
Full text not available from this repository.
Malignant melanoma has been shown to be susceptible to T cell-mediated immunity and, therefore, is a candidate for vaccination approaches. Clinical trials using dendritic cells (DC) loaded with peptides corresponding to tumor antigens are ongoing in several institutions, and some promising results have already been published. However, every single peptide-based vaccine can only be used in a ...
Export bibliographical data
|Institutions:||Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)|
|Dewey Decimal Classification:||600 Technology > 610 Medical sciences Medicine|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Yes|
|Deposited on:||15 Apr 2010 05:10|
|Last modified:||15 Apr 2010 05:10|